At The Texas Heart Institute at Baylor College of Medicine, advancing cardiovascular science is central to our mission, and the latest research from Dr. James F. Martin, Director, Cardiomyocyte Renewal and Gene Editing Laboratories at The Texas Heart Institute at Baylor College of Medicine, and his team represents another important step forward. Their recent publication in Circulation, YAP Induces a Prorenewal Metabolic State in Cardiomyocytes, explores how heart muscle cells can potentially be reprogrammed to regain regenerative capacity, offering promising insights for the future of heart failure treatment.
This work was led by co-first authors Xiao Li and Diwakar Turaga, with contributions from Yi Zhao, Chang-Ru Tsai, Richard Gang Li, Yuka Morikawa, Hanna J. Tadros, Md Abdul Hassan Samee, and Iki Adachi, under the senior authorship of Dr. James F. Martin. The study reflects a highly collaborative effort across The Texas Heart Institute at Baylor College of Medicine, Baylor College of Medicine, and Texas Children’s Hospital.
The study focuses on the role of YAP, a key regulator of cellular signaling, in reshaping how cardiomyocytes, the cells responsible for heart contraction, use energy. The team observed that YAP could shift these cells from a mature metabolic state back toward a more neonatal-like state, which is associated with increased proliferation and tissue repair. By reducing fatty acid utilization and promoting phospholipid biosynthesis, YAP helps create a cellular environment more favorable for regeneration. This work also revealed that YAP suppresses MEF2A, a transcription factor linked to cardiomyocyte maturation, suggesting a potential pathway to restore regenerative capacity in the heart.
Given that adult heart muscle has a very limited ability to repair itself after injury, identifying ways to overcome metabolic barriers to cardiomyocyte renewal moves the field closer to therapies that could repair damaged heart tissue rather than simply manage symptoms. The findings point to future strategies targeting metabolic maturation to support heart regeneration.
“Our goal is to better understand the fundamental biology that limits heart regeneration in adults,” emphasized Dr. Martin. “By identifying mechanisms that can reprogram cardiomyocytes toward a more regenerative state, we are laying the groundwork for future therapies that could help the heart repair itself after injury.”
We congratulate Dr. Martin, his research team, and collaborators on this important contribution to cardiovascular science. Their work underscores THI’s legacy of discovery and reinforces our commitment to translating groundbreaking research into therapies that improve—and save—lives.
Visit U.S. News & World Report
